• Explore /
  • Poster
  • / Multi-omic characterization of acquired resistance to immune checkpoint inhibitors in patients with metastatic renal cell carcinoma.

Multi-omic characterization of acquired resistance to immune checkpoint inhibitors in patients with metastatic renal cell carcinoma.

Abstract Poster

Authors

null

Eddy Saad

Dana-Farber Cancer Institute, Boston, MA

Eddy Saad , Chris Labaki , Benjamin Miron , Jihye Park , Ziad Bakouny , Amin Nassar , Renee Maria Saliby , Karl Semaan , Marc Eid , Kevin Meli , Yasmin Nabil Laimon , Daniel M. Geynisman , Rutika Kokate , David A. Braun , Sabina Signoretti , Bradley Alexander McGregor , Elizabeth R. Plimack , Toni K. Choueiri , Eliezer Mendel Van Allen , Matthew R. Zibelman

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Renal Cell Cancer; Adrenal, Penile, and Testicular Cancers

Track

Renal Cell Cancer,Adrenal Cancer,Penile Cancer,Testicular Cancer

Sub Track

Translational Research, Tumor Biology, Biomarkers, and Pathology

Citation

J Clin Oncol 42, 2024 (suppl 4; abstr 459)

DOI

10.1200/JCO.2024.42.4_suppl.459

Abstract #

459

Poster Bd #

J20

Abstract Disclosures

Similar Posters

First Author: Weihua Guo

First Author: Eddy Saad

First Author: Yu Fujiwara

Poster

2024 ASCO Genitourinary Cancers Symposium

Preclinical testing of a novel PD-L1 inhibitor for the treatment of renal cell carcinoma.

Preclinical testing of a novel PD-L1 inhibitor for the treatment of renal cell carcinoma.

First Author: Michelle Hsu